Development of urinary concentrating capacity

Role of aquaporin-2

Masato Yasui, D. Makples, R. Belusa, A. C. Eklöf, G. Celsi, S. Nielsen, A. Aperia

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The capacity to concentrate urine develops progressively during postnatal life in most mammalian species. Here we have examined whether low expression of the arginine vasopressin (AVP)-activated water channel aquaporin-2 (AQP-2) may be a limiting factor for the concentrating capacity in the infant rats. Urine osmolality in response to 24-h dehydration increased significantly from 10 to 40 days of age. The most rapid increase occurred during the weaning period, i.e., days 15-20. A similar developmental pattern was observed for AQP-2 mRNA levels in the renal medulla. AQP-2 protein levels also increased markedly from day 10 to 40. Immunohistochemistry revealed that AQP-2 was exclusively located in collecting duct principal cells both in infant and adult rats but that the signal was much weaker in infants. To further examine the relationship between urinary concentrating capacity and AQP-2 expression, we treated rats with a single injection of betamethasone, which is known to accelerate maturation in several organs. Twenty-four hours after treatment, there was an increase in urine osmolality, renal medullary AQP-2 mRNA, and AQP-2 protein levels in infant but not in adult rats. A single injection of a specific V2 agonist caused within 6 h significant increase of AQP-2 mRNA in both infant arid adult. The expression of the mRNA of three other transporters involved in the concentrating process, medullary Na+-K+ATPase a-subunit, Na-K-2Cl cotransporter, and epithelial chloride channel also increased during the weaning period and were upregulated by glucocorticoids. We conclude that there is a well-synchronized development of the many of the components that determine the concentrating capacity and that the low expression of AQP-2 is one of the limiting factors for low concentrating capacity in infants.

Original languageEnglish
JournalAmerican Journal of Physiology
Volume271
Issue number2 PART 2
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Aquaporin 2
Messenger RNA
Urine
Weaning
Osmolar Concentration
Kidney
Betamethasone
Aquaporins
Chloride Channels
Injections
Arginine Vasopressin
Dehydration
Glucocorticoids
Proteins
Immunohistochemistry

Keywords

  • Antidiuretic hormones
  • Ontogeny
  • Steroid hormones
  • Water transport

ASJC Scopus subject areas

  • Physiology (medical)
  • Physiology

Cite this

Yasui, M., Makples, D., Belusa, R., Eklöf, A. C., Celsi, G., Nielsen, S., & Aperia, A. (1996). Development of urinary concentrating capacity: Role of aquaporin-2. American Journal of Physiology, 271(2 PART 2).

Development of urinary concentrating capacity : Role of aquaporin-2. / Yasui, Masato; Makples, D.; Belusa, R.; Eklöf, A. C.; Celsi, G.; Nielsen, S.; Aperia, A.

In: American Journal of Physiology, Vol. 271, No. 2 PART 2, 1996.

Research output: Contribution to journalArticle

Yasui, M, Makples, D, Belusa, R, Eklöf, AC, Celsi, G, Nielsen, S & Aperia, A 1996, 'Development of urinary concentrating capacity: Role of aquaporin-2', American Journal of Physiology, vol. 271, no. 2 PART 2.
Yasui M, Makples D, Belusa R, Eklöf AC, Celsi G, Nielsen S et al. Development of urinary concentrating capacity: Role of aquaporin-2. American Journal of Physiology. 1996;271(2 PART 2).
Yasui, Masato ; Makples, D. ; Belusa, R. ; Eklöf, A. C. ; Celsi, G. ; Nielsen, S. ; Aperia, A. / Development of urinary concentrating capacity : Role of aquaporin-2. In: American Journal of Physiology. 1996 ; Vol. 271, No. 2 PART 2.
@article{9f771819fa05479fab47d8780f30e25c,
title = "Development of urinary concentrating capacity: Role of aquaporin-2",
abstract = "The capacity to concentrate urine develops progressively during postnatal life in most mammalian species. Here we have examined whether low expression of the arginine vasopressin (AVP)-activated water channel aquaporin-2 (AQP-2) may be a limiting factor for the concentrating capacity in the infant rats. Urine osmolality in response to 24-h dehydration increased significantly from 10 to 40 days of age. The most rapid increase occurred during the weaning period, i.e., days 15-20. A similar developmental pattern was observed for AQP-2 mRNA levels in the renal medulla. AQP-2 protein levels also increased markedly from day 10 to 40. Immunohistochemistry revealed that AQP-2 was exclusively located in collecting duct principal cells both in infant and adult rats but that the signal was much weaker in infants. To further examine the relationship between urinary concentrating capacity and AQP-2 expression, we treated rats with a single injection of betamethasone, which is known to accelerate maturation in several organs. Twenty-four hours after treatment, there was an increase in urine osmolality, renal medullary AQP-2 mRNA, and AQP-2 protein levels in infant but not in adult rats. A single injection of a specific V2 agonist caused within 6 h significant increase of AQP-2 mRNA in both infant arid adult. The expression of the mRNA of three other transporters involved in the concentrating process, medullary Na+-K+ATPase a-subunit, Na-K-2Cl cotransporter, and epithelial chloride channel also increased during the weaning period and were upregulated by glucocorticoids. We conclude that there is a well-synchronized development of the many of the components that determine the concentrating capacity and that the low expression of AQP-2 is one of the limiting factors for low concentrating capacity in infants.",
keywords = "Antidiuretic hormones, Ontogeny, Steroid hormones, Water transport",
author = "Masato Yasui and D. Makples and R. Belusa and Ekl{\"o}f, {A. C.} and G. Celsi and S. Nielsen and A. Aperia",
year = "1996",
language = "English",
volume = "271",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2 PART 2",

}

TY - JOUR

T1 - Development of urinary concentrating capacity

T2 - Role of aquaporin-2

AU - Yasui, Masato

AU - Makples, D.

AU - Belusa, R.

AU - Eklöf, A. C.

AU - Celsi, G.

AU - Nielsen, S.

AU - Aperia, A.

PY - 1996

Y1 - 1996

N2 - The capacity to concentrate urine develops progressively during postnatal life in most mammalian species. Here we have examined whether low expression of the arginine vasopressin (AVP)-activated water channel aquaporin-2 (AQP-2) may be a limiting factor for the concentrating capacity in the infant rats. Urine osmolality in response to 24-h dehydration increased significantly from 10 to 40 days of age. The most rapid increase occurred during the weaning period, i.e., days 15-20. A similar developmental pattern was observed for AQP-2 mRNA levels in the renal medulla. AQP-2 protein levels also increased markedly from day 10 to 40. Immunohistochemistry revealed that AQP-2 was exclusively located in collecting duct principal cells both in infant and adult rats but that the signal was much weaker in infants. To further examine the relationship between urinary concentrating capacity and AQP-2 expression, we treated rats with a single injection of betamethasone, which is known to accelerate maturation in several organs. Twenty-four hours after treatment, there was an increase in urine osmolality, renal medullary AQP-2 mRNA, and AQP-2 protein levels in infant but not in adult rats. A single injection of a specific V2 agonist caused within 6 h significant increase of AQP-2 mRNA in both infant arid adult. The expression of the mRNA of three other transporters involved in the concentrating process, medullary Na+-K+ATPase a-subunit, Na-K-2Cl cotransporter, and epithelial chloride channel also increased during the weaning period and were upregulated by glucocorticoids. We conclude that there is a well-synchronized development of the many of the components that determine the concentrating capacity and that the low expression of AQP-2 is one of the limiting factors for low concentrating capacity in infants.

AB - The capacity to concentrate urine develops progressively during postnatal life in most mammalian species. Here we have examined whether low expression of the arginine vasopressin (AVP)-activated water channel aquaporin-2 (AQP-2) may be a limiting factor for the concentrating capacity in the infant rats. Urine osmolality in response to 24-h dehydration increased significantly from 10 to 40 days of age. The most rapid increase occurred during the weaning period, i.e., days 15-20. A similar developmental pattern was observed for AQP-2 mRNA levels in the renal medulla. AQP-2 protein levels also increased markedly from day 10 to 40. Immunohistochemistry revealed that AQP-2 was exclusively located in collecting duct principal cells both in infant and adult rats but that the signal was much weaker in infants. To further examine the relationship between urinary concentrating capacity and AQP-2 expression, we treated rats with a single injection of betamethasone, which is known to accelerate maturation in several organs. Twenty-four hours after treatment, there was an increase in urine osmolality, renal medullary AQP-2 mRNA, and AQP-2 protein levels in infant but not in adult rats. A single injection of a specific V2 agonist caused within 6 h significant increase of AQP-2 mRNA in both infant arid adult. The expression of the mRNA of three other transporters involved in the concentrating process, medullary Na+-K+ATPase a-subunit, Na-K-2Cl cotransporter, and epithelial chloride channel also increased during the weaning period and were upregulated by glucocorticoids. We conclude that there is a well-synchronized development of the many of the components that determine the concentrating capacity and that the low expression of AQP-2 is one of the limiting factors for low concentrating capacity in infants.

KW - Antidiuretic hormones

KW - Ontogeny

KW - Steroid hormones

KW - Water transport

UR - http://www.scopus.com/inward/record.url?scp=0029781618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029781618&partnerID=8YFLogxK

M3 - Article

VL - 271

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 2 PART 2

ER -